Investigating Heart Disease in Small Arteries in Men and Women

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to understand the prevalence of microvascular disease in individuals with Cardiac Syndrome X, particularly focusing on women who experience chest pain without significant blockages in large heart arteries. It will evaluate the effectiveness of noninvasive tests like Peripheral Artery Tonometry and Cardiac Magnetic Resonance in diagnosing this condition. Participants will undergo specialized testing during heart catheterization to assess abnormalities in their small heart arteries, while also providing detailed medical histories through questionnaires. The research seeks to improve diagnosis and treatment options for patients suffering from microvascular angina.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Women and men with signs and symptoms of myocardial ischemia and angina or angina equivalent (chest pain, abnormal stress testing, abnormal noninvasive testing) or microvascular angina (MVA) which is defined as angina and ischemic ECG changes without organic obstructive stenosis or epicardial spasm of the coronary arteries
2. No obstructive coronary artery disease performed within the previous 24 months (\<50% luminal obstruction in one or more coronary arteries on angiography).
3. Age \> 18 years old
4. Competent to give informed consent

Exclusion Criteria:

1. Obstructive CAD ≥ 50% luminal diameter stenosis in ≥ 1 epicardial coronary artery,
2. Acute coronary syndrome (defined by the ACC/AHA criteria, Braunwald 2000),
3. Primary valvular heart disease clearly indicating the need for valve repair or replacement;
4. Patients with concurrent cardiogenic shock or requiring inotropic or intra-aortic balloon support;
5. Prior or planned percutaneous coronary intervention or CABG or prior acute MI in prior 30 days;
6. Prior non-cardiac illness with an estimated life expectancy \<4 years;
7. Unable to give informed consent;
8. Chest pain with a non-ischemic etiology (e.g.,pericarditis, pneumonia, esophageal spasm);
9. Contraindications to adenosine or Regadenoson (Lexiscan)
10. Women and men with intermediate coronary stenoses (\>20% but \<50% luminal diameter stenosis assessed visually at the time of angiography) will undergo clinically indicated IVUS testing based on the judgment of the operator; those determined to have flow FFR or obstructing stenosis will be excluded from the overall study.
11. Heart failure (NYHA Class III or IV on treatment)
12. LV dysfunction (ejection fraction \<40%)
13. Documented obstructive myocardiopathy

Where it's running

• Cedars-Sinai Women's Heart Center
  Los Angeles, California, United States Recruiting

Study contacts

• Principal investigator: C.Noel Bairey-Merz, MD — Cedars-Sinai Medical Center
• Study coordinator: Barbra Streisand Women's Heart Center
• Phone: 310-423-9666

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Differentiating heart disease in autoimmune vs. type 2 diabetes

  This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.

  Recruiting University of Roma La Sapienza · Rome, Roma · NCT07911007

• Cardiac Function and Anesthesia Depth During Heart Surgery

  This study tests whether deeper or lighter anesthesia affects heart function during elective heart surgery with bypass in adults.

  Recruiting AHEPA University Hospital · Thessaloniki · NCT07770269

• DigitHeart Echo: predicting heart ultrasound findings from a smartphone photo of your ECG

  This test checks whether a smartphone app can predict echocardiogram findings from a photo of a 12‑lead ECG in adults scheduled for echocardiography.

  Recruiting The University of Hong Kong · Hong Kong · NCT07558109

• Using blood flow measurements during bypass surgery to predict graft openness and recovery

  This trial will test whether using a device that measures blood flow during coronary bypass surgery helps surgeons ensure grafts stay open and improves recovery for adults having their first non-emergency multivessel CABG.

  Recruiting Weill Medical College of Cornell University · New York, New York · NCT07485738

• Tiny ultrasound bubbles as an alternative to catheters for measuring pressures inside the heart

  This will test whether injecting tiny ultrasound bubbles can estimate heart filling pressures in people who are having a cardiac catheterisation.

  Recruiting King's College London · London · NCT07416279

• Using the Supira percutaneous ventricular assist device during and after high-risk PCI

  This study will try the Supira percutaneous ventricular assist device to give extra heart support during and after high-risk PCI for patients with heart failure and reduced ejection fraction.

  Recruiting at 2 sites Supira Medical · Tbilisi, K'alak'i T'bilisi and 1 other locations · NCT07407816

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.